← United States · Coverage record
US · SEC FORM 4
TALPHERA, INC.
TLPH · Nasdaq · CIK 0001427925 · Healthcare · Drug Manufacturers—Specialty & Generic
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
8 Form 4 transaction lines observed in the same window
0 sales · 8 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 2 additional owner(s) remain in Form 4 evidence.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-03-13 · Angotti Vincent J..
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 721,534
- Previous report
- 700,723
- Avg daily volume
- 114,216
- Days to cover
- 6.3
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-03-13 | Angotti Vincent J. | Purchase (P) | Common Stock | 213,310 | USD 0.59 | USD 125,853 | SEC filing ↗ |
| 2026-02-12 | Dasu Badri N | Purchase (P) | Common Stock | 35,000 | USD 0.81 | USD 28,350 | SEC filing ↗ |
| 2026-02-12 | Aslam Shakil | Purchase (P) | Common Stock | 35,000 | USD 0.81 | USD 28,350 | SEC filing ↗ |
| 2026-02-12 | Angotti Vincent J. | Purchase (P) | Common Stock | 105,364 | USD 0.81 | USD 85,345 | SEC filing ↗ |
| 2026-02-12 | ASADORIAN RAFFI | Purchase (P) | Commom Stock | 45,000 | USD 0.81 | USD 36,450 | SEC filing ↗ |
| 2025-04-02 | Angotti Vincent J. | Purchase (P) | Common Stock | 213,310 | USD 0.59 | USD 125,853 | SEC filing ↗ |
| 2024-12-05 | Angotti Vincent J. | Purchase (P) | Common Stock | 5,000 | USD 0.64 | USD 3,200 | SEC filing ↗ |
| 2024-11-27 | Angotti Vincent J. | Purchase (P) | Common Stock | 5,000 | USD 0.73 | USD 3,650 | SEC filing ↗ |
| 2024-08-30 | Angotti Vincent J. | Purchase (P) | Common Stock | 7,260 | USD 1.05 | USD 7,623 | SEC filing ↗ |
| 2024-06-14 | Aslam Shakil | Purchase (P) | Common Stock | 5,000 | USD 1.07 | USD 5,350 | SEC filing ↗ |
| 2024-06-14 | Angotti Vincent J. | Purchase (P) | Common Stock | 1,304 | USD 1.08 | USD 1,408 | SEC filing ↗ |
| 2024-06-13 | Aslam Shakil | Purchase (P) | Common Stock | 695 | USD 0.98 | USD 681 | SEC filing ↗ |
| 2024-06-13 | Angotti Vincent J. | Purchase (P) | Common Stock | 4,570 | USD 0.97 | USD 4,433 | SEC filing ↗ |
| 2024-06-12 | Angotti Vincent J. | Purchase (P) | Common Stock | 4,126 | USD 0.97 | USD 4,002 | SEC filing ↗ |
| 2023-12-13 | Angotti Vincent J. | Purchase (P) | Common Stock | 10,000 | USD 0.73 | USD 7,300 | SEC filing ↗ |
Form 4 evidence
29 transaction lines in the latest 365-day window; 171 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-06-22 | WAN MARK A | Award / grant (A) | Common Stock | 5,100 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-22 | Todisco Joseph | Award / grant (A) | Common Stock | 5,100 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-22 | JAIN ABHINAV | Award / grant (A) | Common Stock | 5,100 | USD 0.00 | USD 0 | SEC filing ↗ |
Show recent Form 4 evidence (29 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-06-22 | WAN MARK A | Award / grant (A) | Common Stock | 5,100 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-22 | Todisco Joseph | Award / grant (A) | Common Stock | 5,100 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-22 | JAIN ABHINAV | Award / grant (A) | Common Stock | 5,100 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-22 | HOFFMAN STEPHEN J | Award / grant (A) | Common Stock | 5,100 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-22 | Broadfoot Jill Marie | Award / grant (A) | Common Stock | 5,100 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-22 | Bozilenko Marina | Award / grant (A) | Common Stock | 5,100 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-22 | ADAMS ADRIAN | Award / grant (A) | Common Stock | 5,100 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-20 | Aslam Shakil | Tax withholding (F) | Common Stock | 4,518 | USD 0.82 | USD 3,705 | SEC filing ↗ |
| 2026-04-02 | Dasu Badri N | Tax withholding (F) | Common Stock | 2,444 | USD 0.72 | USD 1,760 | SEC filing ↗ |
| 2026-04-02 | Aslam Shakil | Tax withholding (F) | Common Stock | 2,118 | USD 0.72 | USD 1,525 | SEC filing ↗ |
| 2026-04-02 | Angotti Vincent J. | Tax withholding (F) | Common Stock | 9,938 | USD 0.72 | USD 7,155 | SEC filing ↗ |
| 2026-04-02 | ASADORIAN RAFFI | Tax withholding (F) | Common Stock | 2,444 | USD 0.72 | USD 1,760 | SEC filing ↗ |
| 2026-03-13 | Angotti Vincent J. | Purchase (P) | Common Stock | 213,310 | USD 0.59 | USD 125,853 | SEC filing ↗ |
| 2026-02-14 | Dasu Badri N | Tax withholding (F) | Common Stock | 2,346 | USD 0.79 | USD 1,853 | SEC filing ↗ |
| 2026-02-14 | Angotti Vincent J. | Tax withholding (F) | Common Stock | 9,559 | USD 0.79 | USD 7,552 | SEC filing ↗ |
| 2026-02-14 | ASADORIAN RAFFI | Tax withholding (F) | Common Stock | 2,933 | USD 0.79 | USD 2,317 | SEC filing ↗ |
| 2026-02-12 | Dasu Badri N | Purchase (P) | Common Stock | 35,000 | USD 0.81 | USD 28,350 | SEC filing ↗ |
| 2026-02-12 | Aslam Shakil | Purchase (P) | Common Stock | 35,000 | USD 0.81 | USD 28,350 | SEC filing ↗ |
| 2026-02-12 | Angotti Vincent J. | Purchase (P) | Common Stock | 105,364 | USD 0.81 | USD 85,345 | SEC filing ↗ |
| 2026-02-12 | ASADORIAN RAFFI | Purchase (P) | Commom Stock | 45,000 | USD 0.81 | USD 36,450 | SEC filing ↗ |
| 2026-02-10 | Dasu Badri N | Tax withholding (F) | Common Stock | 781 | USD 0.84 | USD 656 | SEC filing ↗ |
| 2026-02-10 | Angotti Vincent J. | Tax withholding (F) | Common Stock | 3,179 | USD 0.84 | USD 2,670 | SEC filing ↗ |
| 2026-02-10 | ASADORIAN RAFFI | Tax withholding (F) | Common Stock | 958 | USD 0.84 | USD 805 | SEC filing ↗ |
| 2025-10-23 | WAN MARK A | Award / grant (A) | Common Stock | 4,267 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-10-23 | JAIN ABHINAV | Award / grant (A) | Common Stock | 4,267 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-10-23 | HOFFMAN STEPHEN J | Award / grant (A) | Common Stock | 4,267 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-10-23 | Broadfoot Jill Marie | Award / grant (A) | Common Stock | 4,267 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-10-23 | Bozilenko Marina | Award / grant (A) | Common Stock | 4,267 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-10-23 | ADAMS ADRIAN | Award / grant (A) | Common Stock | 4,267 | USD 0.00 | USD 0 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | TLPH |
| CIK | 0001427925 |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 171 transaction lines from 2020-02-06 to 2026-06-22 20 P purchase lines · 3 S sale lines · 148 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.